Filing Details
- Accession Number:
- 0000950170-25-075539
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-20 21:46:49
- Reporting Period:
- 2025-05-20
- Filing Date:
- 2025-05-20
- Accepted Time:
- 2025-05-20 21:46:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1579428 | Axsome Therapeutics Inc. | AXSM | Pharmaceutical Preparations (2834) | 454241907 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1658379 | Mark Coleman | C/O Axsome Therapeutics, Inc. One World Trade Center, 29Th Floor New York NY 10007 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-05-20 | 3,000 | $107.49 | 54,137 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 403,856 | Indirect | See Footnote |
Footnotes
- Represents the sale of underlying shares of previously exercised stock options.
- Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $107.34 and $107.65.
- Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.